The CDC’s guidelines call for medications labeled as “single dose” or “single use” to be used for only one patient. The practice is intended to protect patients from infections that occur when medications get contaminated from unsafe use. Concerns have been raised about whether these guidelines and related policies contribute to drug shortages and increased medical costs to healthcare providers. While the CDC recognizes the problem of drug shortages, it says such shortages are a result of manufacturing, shipping and other issues unrelated to its guidelines.
The CDC’s restatement also includes general messages, basic safe infection practice messages, a table listing misconceptions and facts, answers to frequently asked questions and additional resources.
Related Articles on Infections:
ICU Hospitalist Model May Improve LOS, Infection Rates, Costs and Patient Satisfaction
Antimicrobial Resistance to Common UTI Drug Increases 5-Fold
Study Reveals Impact of CMS Payment Adjustment for HAIs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
